Johanna Wittreich

Characterization of rofecoxib as a cyclooxygenase-2 isoform inhibitor and demonstration of analgesia in the dental pain model

Elliot Ehrich, A. Dallob, I Delepeleire et al. · Clinical Pharmacology & Therapeutics · 1999 · 326 citations

Prevention of Cisplatin-Induced Emesis by the Oral Neurokinin-1 Antagonist, MK-869, in Combination With Granisetron and Dexamethasone or With Dexamethasone Alone

José Rodrigues Pereira, Rick R. Reinhardt, Carlos Carracedo et al. · Journal of Clinical Oncology · 2001 · 221 citations

Growth hormone response in man to L-692,429, a novel nonpeptide mimic of growth hormone-releasing peptide-6.

B. J. Gertz, Jeffrey S. Barrett, Roy Eisenhandler et al. · The Journal of Clinical Endocrinology & Metabolism · 1993 · 98 citations

Human Growth, Peptide Science, Gastrointestinal Peptide Hormone +17

MK-677, an Orally Active Growth Hormone Secretagogue, Reverses Diet-Induced Catabolism1

M. Gail Murphy, Laura M. Plunkett, B. J. Gertz et al. · The Journal of Clinical Endocrinology & Metabolism · 1998 · 89 citations · Full text

Oral Mk-677 25, Nutrition, Caloric Restriction +19

Neuroendocrine responses to a novel growth hormone secretagogue, L-692,429, in healthy older subjects.

Joseph Aloi, B. J. Gertz, Mark L. Hartman et al. · The Journal of Clinical Endocrinology & Metabolism · 1994 · 74 citations

Human Growth, Neuroendocrinology, Gh-releasing Peptide +18